Bausch Health Companies Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Bausch Health Companies Inc. (BHC) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$97.20 million for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2016-08-09
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2016-06-30 was -$97.20M, a 370.75% decline year-over-year.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2016-03-31 was $63.50M.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2015-12-31 was -$79.80M.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2015-09-30 was -$173.70M.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2015 was -$629.50M.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2014 was -$784.70M.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2013 was -$13.10M, a 108.18% decline from fiscal 2012.
- Bausch Health Companies Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2012 was $160.20M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-06-30 | -$97.20M 10-Q · filed 2016-08-09 | -$33.70M 10-Q · filed 2016-08-09 | -$113.50M derived: sum of 3 quarters · filed 2016-08-09 | -$287.20M derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2016-03-31 | $63.50M 10-Q · filed 2016-06-07 | -$16.30M derived: sum of 2 quarters · filed 2016-06-07 | -$190.00M derived: sum of 3 quarters · filed 2016-06-07 | -$154.10M derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-12-31 | -$79.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | -$253.50M derived: sum of 2 quarters · filed 2016-04-29 | -$217.60M derived: sum of 3 quarters · filed 2016-08-09 | -$629.50M 10-K · filed 2016-04-29 | ||||
| 2015-09-30 | -$173.70M 10-Q · filed 2015-10-26 | -$137.80M derived: sum of 2 quarters · filed 2016-08-09 | -$549.70M 10-Q · filed 2015-10-26 | -$914.70M derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-06-30 | $35.90M 10-Q · filed 2016-08-09 | -$376.00M 10-Q · filed 2016-08-09 | -$741.00M derived: sum of 3 quarters · filed 2016-08-09 | -$1.19B derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-03-31 | -$411.90M 10-Q · filed 2016-06-07 | -$776.90M derived: sum of 2 quarters · filed 2016-06-07 | -$1.22B derived: sum of 3 quarters · filed 2016-06-07 | -$1.19B derived: sum of 4 quarters · filed 2016-06-07 | ||||
| 2014-12-31 | -$365.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | -$811.10M derived: sum of 2 quarters · filed 2016-04-29 | -$776.70M derived: sum of 3 quarters · filed 2016-04-29 | -$784.70M 10-K · filed 2016-04-29 | ||||
| 2014-09-30 | -$446.10M 10-Q · filed 2015-10-26 | -$411.70M derived: sum of 2 quarters · filed 2015-10-26 | -$419.70M 10-Q · filed 2015-10-26 | -$391.30M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $34.40M 10-Q · filed 2015-07-28 | $26.40M 10-Q · filed 2015-07-28 | $54.80M derived: sum of 3 quarters · filed 2016-04-29 | $237.80M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | -$8.00M 10-Q · filed 2015-04-30 | $20.40M derived: sum of 2 quarters · filed 2016-04-29 | $203.40M derived: sum of 3 quarters · filed 2016-04-29 | $56.30M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $28.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $211.40M derived: sum of 2 quarters · filed 2016-04-29 | $64.30M derived: sum of 3 quarters · filed 2016-04-29 | -$13.10M 10-K · filed 2016-04-29 | -$13.05M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $183.00M 10-Q · filed 2014-10-24 | $183.06M 10-Q · filed 2013-11-01 | $35.90M derived: sum of 2 quarters · filed 2014-10-24 | -$41.50M 10-Q · filed 2014-10-24 | -$41.45M 10-Q · filed 2013-11-01 | $12.40M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | -$147.10M 10-Q · filed 2014-08-01 | -$147.10M 10-Q · filed 2013-08-07 | -$224.50M 10-Q · filed 2014-08-01 | -$224.50M 10-Q · filed 2013-08-07 | -$170.60M derived: sum of 3 quarters · filed 2015-02-25 | -$56.02M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | -$77.40M 10-Q · filed 2014-05-09 | -$77.40M 10-Q · filed 2013-05-03 | -$23.50M derived: sum of 2 quarters · filed 2015-02-25 | $91.08M derived: sum of 3 quarters · filed 2015-02-25 | -$111.47M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $53.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $168.48M derived: sum of 2 quarters · filed 2015-02-25 | -$34.08M derived: sum of 3 quarters · filed 2015-02-25 | $160.20M 10-K · filed 2015-02-25 | $160.22M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $114.58M 10-Q · filed 2013-11-01 | $107.13M 10-Q · filed 2012-11-05 | -$87.97M derived: sum of 2 quarters · filed 2013-11-01 | $106.30M 10-Q · filed 2013-11-01 | $82.59M 10-Q · filed 2012-11-05 | $12.95M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-06-30 | -$202.55M 10-Q · filed 2013-08-07 | -$197.44M 10-Q · filed 2012-08-03 | -$8.28M 10-Q · filed 2013-08-07 | -$24.54M 10-Q · filed 2012-08-03 | -$101.63M derived: sum of 3 quarters · filed 2014-02-28 | -$570.82M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-03-31 | $194.28M 10-Q · filed 2013-05-03 | $172.91M 10-Q · filed 2012-05-04 | $100.93M derived: sum of 2 quarters · filed 2014-02-28 | -$368.27M derived: sum of 3 quarters · filed 2014-02-28 | -$302.96M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2011-12-31 | -$93.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$562.54M derived: sum of 2 quarters · filed 2014-02-28 | -$497.23M derived: sum of 3 quarters · filed 2014-02-28 | -$378.45M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | -$469.20M 10-Q · filed 2012-11-05 | -$403.88M derived: sum of 2 quarters · filed 2012-11-05 | -$285.11M 10-Q · filed 2012-11-05 | |||||
| 2011-06-30 | $65.31M 10-Q · filed 2012-08-03 | $184.09M 10-Q · filed 2012-08-03 | ||||||
| 2011-03-31 | $118.78M 10-Q · filed 2012-05-04 | |||||||
| 2010-12-31 | $55.26M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |